Rodin Therapeutics

illustration of brain using branches for AI

Biotech

Struggling Alkermes spends $950M sculpting Rodin buyout

After announcing it was slashing scores of jobs, Alkermes is now willing to put down nearly $1 billion to buy out CNS biotech Rodin Therapeutics.

Ben Adams Nov 18, 2019 10:11am

Martinostat imaging of the human brain

Rodin to test imaging agent to visualize brain synapses

Oct 24, 2018 4:01pm

Boston

Atlas-incubated Rodin gains $27M for neurological work

Sep 18, 2017 7:00am